Abstract:OBJECTIVES:Heme oxygenase-1 is inducible in cardiomyocytes in response to stimuli such as oxidative stress and plays critical roles in combating cardiac hypertrophy and injury. Signal transducer and activator of transcription 3 plays a pivotal role in heme oxygenase-1-mediated protection against liver and lung injuries under oxidative stress. We hypothesized that propofol, an anesthetic with antioxidant capacity, may attenuate hyperglycemia-induced oxidative stress in cardiomyocytes via enhancing heme oxygenase-1 activation and ameliorate hyperglycemia-induced cardiac hypertrophy and apoptosis via heme oxygenase-1/signal transducer and activator of transcription 3 signaling and improve cardiac function in diabetes. DESIGN:Treatment study. SETTING:Research laboratory. SUBJECTS:Sprague-Dawley rats. INTERVENTIONS:In vivo and in vitro treatments. MEASUREMENTS AND MAIN RESULTS:At 8 weeks of streptozotocin-induced type 1 diabetes in rats, myocardial 15-F2t-isoprostane was significantly increased, accompanied by cardiomyocyte hypertrophy and apoptosis and impaired left ventricular function that was coincident with reduced heme oxygenase-1 activity and signal transducer and activator of transcription 3 activation despite an increase in heme oxygenase-1 protein expression as compared to control. Propofol infusion (900 μg/kg/min) for 45 minutes significantly improved cardiac function with concomitantly enhanced heme oxygenase-1 activity and signal transducer and activator of transcription activation. Similar to the changes seen in diabetic rat hearts, high glucose (25 mmol/L) exposure for 48 hours led to cardiomyocyte hypertrophy and apoptosis, both in primary cultured neonatal rat cardiomyocytes and in H9c2 cells compared to normal glucose (5.5 mmol/L). Hypertrophy was accompanied by increased reactive oxygen species and malondialdehyde production and caspase-3 activity. Propofol, similar to the heme oxygenase-1 inducer cobalt protoporphyrin, significantly increased cardiomyocyte heme oxygenase-1 and p-signal transducer and activator of transcription protein expression and heme oxygenase-1 activity and attenuated high-glucose-mediated cardiomyocyte hypertrophy and apoptosis and reduced reactive oxygen species and malondialdehyde production (p < 0.05). These protective effects of propofol were abolished by heme oxygenase-1 inhibition with zinc protoporphyrin and by heme oxygenase-1 or signal transducer and activator of transcription 3 gene knockdown. CONCLUSIONS:Heme oxygenase-1/signal transducer and activator of transcription 3 signaling plays a critical role in propofol-mediated amelioration of hyperglycemia-induced cardiomyocyte hypertrophy and apoptosis, whereby propofol improves cardiac function in diabetic rats.

Propofol Attenuates Myocardial Ischemia Reperfusion Injury Partly Through Inhibition of Resident Cardiac Mast Cell Activation

Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway

Propofol pretreatment reduces ceramide production and attenuates intestinal mucosal apoptosis induced by intestinal ischemia/reperfusion in rats.

Propofol relieves inflammation in MIRI rats by inhibiting Rho/Rock signaling pathway

Construction of preclinical evidence for propofol in the treatment of reperfusion injury after acute myocardial infarction: A systematic review and meta-analysis

Postconditioning of Sevoflurane and Propofol is Associated with Mitochondrial Permeability Transition Pore

Propofol Prevents Cerebral Ischemia-Triggered Autophagy Activation and Cell Death in the Rat Hippocampus Through the NF-κB/p53 Signaling Pathway

Effect of Propofol on Microtubule-Associated Protein 1 Light Chain 3 Following Myocardial Ischemia/reperfusion Injury of Rats

Effects of Propofol on Cardiac Function and Mir-494 Expression in Rats with Hepatic Ischemia/reperfusion Injury.

Propofol Attenuates Cerebral Ischemia/reperfusion Injury Partially Using Heme Oxygenase-1.

Propofol pretreatment inhibits ferroptosis and alleviates myocardial ischemia-reperfusion injury through the SLC16A13-AMPK-GPX4 pathway

Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription 3 signaling pathway in rats.

Effects of Propofol on Myocardial Ischemia-Reperfusion Injury in Rats with Type-2 Diabetes Mellitus.

Propofol Prevents Renal Ischemia-Reperfusion Injury Via Inhibiting the Oxidative Stress Pathways

Propofol Attenuates H2O2-induced Oxidative Stress and Apoptosis Via the Mitochondria- and ER-medicated Pathways in Neonatal Rat Cardiomyocytes.

Propofol Prevents Autophagic Cell Death Following Oxygen and Glucose Deprivation in Pc12 Cells and Cerebral Ischemia-Reperfusion Injury in Rats

Effects of Propofol on LC3II and Mtor/p-Mtor Expression During Ischemia-Reperfusion Myocardium Injury in Rats with Type 2 Diabetes Mellitus

Cardioprotective Effect of Propofol Against Oxygen Glucose Deprivation and Reperfusion Injury in H9c2 Cells

Effects of propofol pretreatment on cytokines and protection on hepatic ischemia-reperfusion-induced lung injury in rats

Propofol protects cardiomyocytes from doxorubicin-induced toxic injury by activating the nuclear factor erythroid 2-related factor 2/glutathione peroxidase 4 signaling pathways

The role of AMPK-Sirt1-autophagy pathway in the intestinal protection process by propofol against regional ischemia/reperfusion injury in rats